mHealth Intelligence July 9, 2024
A study shows that a remote symptom monitoring app providing tailored text messages reduced high-cost healthcare encounters among early-stage breast cancer patients.
While a remote monitoring application offering tailored text messages did not improve adjuvant endocrine therapy (AET) adherence among women with early-stage breast cancer, it did reduce high-cost healthcare encounters without affecting quality of life, according to new research.
AET can help reduce the risk of cancer recurrence among women with early-stage, hormone receptor-positive breast cancer. AET includes drugs that block estrogen receptors, like Tamoxifen and Fulvestrant (Faslodex), drugs that lower estrogen levels, like aromatase inhibitors, and ovarian suppression treatments. However, AET is associated with adverse symptoms, which reduce adherence.
Researchers examined the efficacy of a remote symptom monitoring...
Today's Sponsors
Today's Sponsor